Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein
Summary: Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acquisition of virus-neutralizing antibodies (nAbs) tha...
Main Authors: | Daniel Wright, Elizabeth R. Allen, Madeleine H.A. Clark, John N. Gitonga, Henry K. Karanja, Ruben J.G. Hulswit, Iona Taylor, Sumi Biswas, Jennifer Marshall, Damaris Mwololo, John Muriuki, Bernard Bett, Thomas A. Bowden, George M. Warimwe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004220308610 |
Similar Items
-
Virulence characterization of Rift Valley fever virus strains and efficacy of glycoprotein subunit vaccines in mice
by: Balogh, Aaron Michael
Published: (2016) -
Characterisation of hepatitis C virus genotype 3 glycoproteins
by: Shaw, Magan Louise
Published: (2001) -
The interactome of Rift Valley fever phlebovirus : towards the identification of new intervention strategies
by: Mottram, Timothy James
Published: (2018) -
Characterization of a Putative Quaternary Neutralizing Epitope on the Lassa Virus Glycoprotein
by: Bradley, Benjamin T.
Published: (2017) -
Cytomegalovirus Gn Genotypes, Symptoms at Birth, and Sequelae
by: J Gordon Millichap
Published: (2010-08-01)